COVID-19 Lockdown Exit Analysis

Subscribe
Get in touch

Before you go we'd just like to ask you a quick question!

Your vote has been counted in the results below.

If you could vote on Brexit now which option would you choose?
Remain Leave

Japan picks three COVID-19 drug candidates to get research funds

Japan has selected three candidates for COVID-19 treatments to receive subsidies for clinical trials, the health ministry said on Tuesday. The drugs are AstraZeneca Plc's antibody treatment AZD7442, Shionogi & Co's protease inhibitor S-217622, and Fujifilm Holding Corp's antiviral favipiravir, known commercially as Avigan.

Reuters - September 7, 2021

View the full story here: https://www.reuters.com/world/asia-pacific/japan-picks-three-covid-19-drug-candidates-get-research-funds-2021-09-07/

Contact Us

lockdown_exit@nfind.uk
Our contact form
Curator login

Quick Links

Privacy policy
Terms & Conditions
Cookie Policies

© lockdown_exit 2026. All Right Reserved

Keep up to date with COVID-19 Lockdown Exit Analysis

Name*

Email*

Region*

Enter your region from the drop-down menu so we can tailor the news to you.

Privacy Policy | Terms & Conditions | Cookie Policies

Select or add an image to the Image library

Show only large

Search image library using the following tags

Cookie Notice - News Finder - lockdown_exit

We use cookies to enhance your visit to our site.
Read our Privacy policy, Cookie Policies and Terms & Conditions to find out more.